Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8108515 | 0.87 | GAA (0.47) | GAATDP1L3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL8106239 | 0.87 | GAA (0.44) | GAATDP1L3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL8092894 | 0.86 | ALDH1A1 (0.47) | ALDH1A1HPGD | |
| SCHEMBL8106211 | 0.86 | GAA (0.43) | GAATDP1L3MBTL1MAPTALDH1A1 | |
| SCHEMBL8100379 | 0.86 | GAA (0.43) | GAATDP1L3MBTL1MAPTALDH1A1 | |
| SCHEMBL8100257 | 0.85 | GAA (0.45) | GAATDP1L3MBTL1MAPTALDH1A1 | |
| SCHEMBL8108565 | 0.85 | L3MBTL1 (0.43) | GAATDP1L3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL8102130 | 0.84 | GAA (0.47) | GAATDP1L3MBTL1EPHX2 | |
| SCHEMBL8108358 | 0.84 | SMN1; SMN2 (0.42) | GAATDP1L3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL8100607 | 0.83 | L3MBTL1 (0.41) | GAATDP1L3MBTL1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6013674-A | INDENONE AMIDE DERIVATIVES, USEFUL FOR FOR THE INHIBITION OF LEUKOCYTE ADHERENCE TO ENDOTHELIAL CELLS; USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES, AS ARTHRITIS, ASTHAMA, PSORIASIS, RESPIRATORY DISTRESS SYNDROME, STROKE AND ULCER | ELI LILLY AND COMPANY (US) | 2000-01-11 | — | — | US | disclosed |
| EP-0882706-A1 | Cell adhesion inhibitors | ELI LILLY AND COMPANY (US) | 1998-12-09 | — | — | EP | disclosed |